https://orcid.org/0000-0003-3310-6322
References
- van den Noort JC, Bar-On L, Aertbeliën E, et al. European consensus on the concepts and measurement of the pathophysiological neuromuscular responses to passive muscle stretch. Eur J Neurol. 2017;24(7):981-e38.
- Dias CP, Freire B, Goulart NBA, et al. Muscle architecture and torque production in stroke survivors: an observational study. Top Stroke Rehabil. 2017;24(3):206–213.
- Freire B, Dias CP, Goulart NBA, et al. Achilles tendon morphology, plantar flexors torque and passive ankle stiffness in spastic hemiparetic stroke survivors. Clin Biomech. 2017;41:72–76.
- Bohannon RW, Smith MB. Interrater reliability of a Modified Ashworth Scale of muscle spasticity. Phys Ther. 1987;67(2):206–207.
- Lin FM, Sabbahi M. Correlation of spasticity with hyperactive stretch reflexes and motor dysfunction in hemiplegia. Arch Phys Med Rehabil. 1999;80(5):526–530.
- Blackburn M, van Vliet P, Mockett SM. Reliability of measurements obtained with the Modified Ashworth Scale in the lower extremities of people with stroke. Phys Ther. 2002;82(1):25–34.
- Gregson JM, Leathley M, Moore AP, et al. Reliability of the tone assessment scale and the Modified Ashworth Scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil. 1999;80(9):1013–1016.
- Gupta AD, Chu WH, Howell S, et al. A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity. Syst Rev. 2018;7(1):1.
- Foley N, Murie-Fernandez M, Speechley M, et al. Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta-analysis. Eur J Neurol. 2010;17(12):1419–1427.
- Perera S, Mody SH, Woodman RC, et al. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 2006;54(5):743–749.
- Wu T, Li JH, Song HX, et al. Effectiveness of botulinum toxin for lower limbs spasticity after stroke: a systematic review and meta-analysis. Top Stroke Rehabil. 2016;23(3):217–223.
- Sun LC, Chen R, Fu C, et al. Efficacy and safety of botulinum toxin type a for limb spasticity after stroke: a meta-analysis of randomized controlled trials. Biomed Res Int. 2019;2019:1–17.
- Gregson JM, Leathley MJ, Moore AP, et al. Reliability of measurements of muscle tone and muscle power in stroke patients. Age Ageing. 2000;29(3):223–228.
- Moore JL, Potter K, Blankshain K, et al. A core set of outcome measures for adults with neurologic conditions undergoing rehabilitation: a clinical practice guideline. J Neurol Phys Ther. 2018;42(3):174–220.
- Lord SE, McPherson K, McNaughton HK, et al. Community ambulation after stroke: how important and obtainable is it and what measures appear predictive? Arch Phys Med Rehabil. 2004;85(2):234–239.
- Andersson ÅG, Kamwendo K, Seiger Å, et al. How to identify potential fallers in a stroke unit: validity indexes of 4 test methods. J Rehabil Med. 2006;38(3):186–191.
- Tao W, Yan D, Li JH, et al. Gait improvement by low-dose botulinum toxin A injection treatment of the lower limbs in subacute stroke patients. J Phys Ther Sci. 2015;27(3):759–762.
- Chan J, Winter A, Palit M, et al. Are gait and mobility measures responsive to change following botulinum toxin injections in adults with lower limb spasticity? Disabil Rehabil. 2013;35(12):959–967.
- Flansbjer UB, Holmbäck AM, Downham D, et al. Reliability of gait performance tests in men and women with hemiparesis after stroke. J Rehabil Med. 2005;37(2):75–82.
- Mong Y, Teo TW, Ng SS. 5-Repetition sit-to-stand test in subjects with chronic stroke: reliability and validity. Arch Phys Med Rehabil. 2010;91(3):407–413.
- Kwong PWH, Ng SSM, Chung RCK, et al. Foot placement and arm position affect the five times sit-to-stand test time of individuals with chronic stroke. Biomed Res Int. 2014;2014:636530–636535.
- Fheodoroff K, Scheschonka A, Wissel J. Goal analysis in patients with limb spasticity treated with incobotulinumtoxinA in the TOWER study. Disabil Rehabil. 2020;2020:1–7.